Anti-Dopamine Transporter抗体[hDAT-NT] (ab5990)

发表研究结果有使用 ab5990?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab5990 被引用在 8 文献中.

  • Zhou Q  et al. Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease. Nat Commun 7:10332 (2016). ICC ; Mouse . PubMed: 26755131
  • Postupna NO  et al. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Lab Invest 94:1161-72 (2014). Flow Cyt . PubMed: 25068655
  • Hess ME  et al. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 16:1042-8 (2013). PubMed: 23817550
  • Sunico CR  et al. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease. Mol Neurodegener 8:29 (2013). ICC . PubMed: 23985028
  • Garfield AS  et al. Distinct physiological and behavioural functions for parental alleles of imprinted Grb10. Nature 469:534-8 (2011). IHC (PFA fixed) ; Mouse . PubMed: 21270893
  • Chandrasekar V & Dreyer JL Regulation of MiR-124, Let-7d, and MiR-181a in the accumbens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 36:1149-64 (2011). WB . PubMed: 21307844
  • Friling S  et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci U S A 106:7613-8 (2009). IHC ; Mouse . PubMed: 19383789
  • Andersson E  et al. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393-405 (2006). PubMed: 16439212

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册